(Q46034494)

English

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

scientific article published on 27 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

0 references

0 references

1 reference

based on heuristic

inferred from title

Andrew J. Dalley

object named as

Andrew J Dalley

5

0 references

Jason A. Roberts

object named as

Jason A Roberts

1

0 references

object named as

Jeffrey Lipman

6

0 references

Michael S. Roberts

object named as

Michael S Roberts

3

0 references

Carl Kirkpatrick

2

object named as

Carl M J Kirkpatrick

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

author name string

Thomas A Robertson

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

language of work or name

0 references

publication date

27 April 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

64

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

142-150

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Tissue concentrations: do we ever learn?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Microdialysis in peripheral tissues

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Methodological issues in microdialysis sampling for pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Continuous infusion versus intermittent administration of meropenem in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP139

21 January 2018

Identifiers

10.1093/JAC/DKP139

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19398460

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46034494&oldid=1744127928"